How to define responders in osteoarthritis.

How to define responders in osteoarthritis.

BACKGROUND: Osteoarthritis is a clinical syndrome of failure of the joint accompanied by varying degrees of joint pain, functional limitation, and reduced quality of life due to deterioration of articular cartilage and involvement of other joint structures. SCOPE: Regulatory agencies require releva...

Full description

Bibliographic Details
Main Authors:	Cooper, C, Adachi, J, Bardin, T, Berenbaum, F, Flamion, B, Jonsson, H, Kanis, J, Pelousse, F, Lems, W, Pelletier, J, Martel-Pelletier, J, Reiter, S, Reginster, J, Rizzoli, R, Bruyère, O
Format:	Journal article
Language:	English
Published:	2013

Similar Items

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
by: Bruyère, O, et al.
Published: (2014)

Value of biomarkers in osteoarthritis: current status and perspectives.
by: Lotz, M, et al.
Published: (2013)

Republished: Value of biomarkers in osteoarthritis: current status and perspectives.
by: Lotz, M, et al.
Published: (2014)

A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
by: Hiligsmann, M, et al.
Published: (2014)

Osteoarthritis: The Challenge of Establishing a Personalised Treatment
by: Johanne Martel-Pelletier, et al.
Published: (2014-06-01)

WHAT IS THE PREDICTIVE VALUE OF MRI FOR THE OCCURRENCE OF HARD CLINICAL ENDPOINTS IN KNEE OSTEOARTHRITIS?
by: Pelletier, J, et al.
Published: (2013)

Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
by: Bruyère, O, et al.
Published: (2014)

HEALTH ECONOMICS IN OSTEOARTHRITIS
by: Hiligsmann, M, et al.
Published: (2013)

What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?
by: Pelletier, J, et al.
Published: (2013)

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
by: Hiligsmann, M, et al.
Published: (2013)

STRONTIUM RANELATE PREVENTS RADIOLOGICAL PROGRESSION IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS: A RESPONDERS ANALYSIS
by: Cooper, C, et al.
Published: (2013)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
by: Bruyère, O, et al.
Published: (2008)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
by: Rizzoli, R, et al.
Published: (2013)

Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients
by: Guangju Zhai, et al.
Published: (2019-11-01)

Challenges for the development of bone-forming agents in Europe
by: Kanis, J, et al.
Published: (2014)

Challenges for the development of bone-forming agents in Europe.
by: Kanis, J, et al.
Published: (2014)

MULTICENTRIC OSTEOARTHRITIS INTERVENTION STUDY WITH SYSADOA (MOVES): EFFECTS OF COMBINED GLUCOSAMINE HYDROCHLORIDE AND CHONDROITIN SULFATE VS. CELECOXIB FOR PAINFUL KNEE OSTEOARTHRITIS
by: Castillo, JR, et al.
Published: (2014)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
by: Rizzoli, R, et al.
Published: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
by: Rizzoli, R, et al.
Published: (2011)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
by: Cooper, C, et al.
Published: (2012)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
by: Rizzoli René, et al.
Published: (2008-12-01)

Is there a mitochondrial DNA haplogroup connection between osteoarthritis and elite athletes? A narrative review
by: Jean-Pierre Pelletier, et al.
Published: (2022-09-01)

Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
by: Reginster, J, et al.
Published: (2012)

EFFECT OF STRONTIUM RANELATE ON KNEE PAIN IN OSTEOARTHRITIS: A RESPONDER ANALYSIS
by: Cooper, C, et al.
Published: (2013)

A reappraisal of generic bisphosphonates in osteoporosis.
by: Kanis, J, et al.
Published: (2012)

Health technology assessment in osteoporosis.
by: Hiligsmann, M, et al.
Published: (2013)

Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
by: Bruyere, O, et al.
Published: (2013)

Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
by: Mehdi Najar, et al.
Published: (2020-09-01)

Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis
by: Johanne Martel-Pelletier, et al.
Published: (2023-04-01)

Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years.
by: Bruyere, O, et al.
Published: (2013)

STRONTIUM RANELATE PREVENTS SPINE OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH PREVALENT SPINAL OSTEOARTHRITIS
by: O Bruyere, et al.
Published: (2007-08-01)

Partial adherence: a new perspective on health economic assessment in osteoporosis.
by: Kanis, J, et al.
Published: (2011)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
by: Kanis, J, et al.
Published: (2008)

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
by: Rizzoli, R, et al.
Published: (2014)

Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate
by: Reginster, J, et al.
Published: (2013)

Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
by: Bruyere, O, et al.
Published: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
by: Kanis, J, et al.
Published: (2008)

Common Biochemical and Magnetic Resonance Imaging Biomarkers of Early Knee Osteoarthritis and of Exercise/Training in Athletes: A Narrative Review
by: Johanne Martel-Pelletier, et al.
Published: (2021-08-01)